Embecta (EMBC) Non-Current Deferred Tax Liability (2021 - 2026)
Embecta (EMBC) posted Non-Current Deferred Tax Liability of $63.4 million for Q1 2026, up 3.93% sequentially from $61.0 million in Q4 2025, and up 8.38% YoY from $58.5 million in Q1 2025.
Embecta (EMBC) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
Embecta has reported Non-Current Deferred Tax Liability for 6 years, with the latest figure at $63.4 million in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability rose 8.38% year-over-year to $63.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.4 million (up 8.38% YoY) and the FY2025 annual result came in at $62.6 million, up 15.71% from the prior year.
- Non-Current Deferred Tax Liability rose to $63.4 million in Q1 2026 per EMBC's latest filing, from $61.0 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $63.5 million in Q2 2025 and troughed at $31.4 million in Q1 2022.
- A 5-year average of $50.3 million and a median of $54.1 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability surged 82.28% in 2023, then retreated 22.81% in 2024.
- Over 5 years, Non-Current Deferred Tax Liability stood at $33.3 million in 2022, then surged by 82.28% to $60.7 million in 2023, then declined by 8.4% to $55.6 million in 2024, then gained by 9.71% to $61.0 million in 2025, then advanced by 3.93% to $63.4 million in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $63.4 million, $61.0 million, and $62.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 115.10 Mn |
| Jun 30, 2026 | 115.10 Mn |
| Mar 31, 2026 | 63.40 Mn |
| Mar 31, 2026 | 63.40 Mn |
| Dec 31, 2025 | 61.00 Mn |
| Dec 31, 2025 | 61.00 Mn |
| Sep 30, 2025 | 62.60 Mn |
| Sep 30, 2025 | 62.60 Mn |
| Jun 30, 2025 | 63.50 Mn |
| Jun 30, 2025 | 63.50 Mn |
| Mar 31, 2025 | 58.50 Mn |
| Mar 31, 2025 | 58.50 Mn |
| Dec 31, 2024 | 55.60 Mn |
| Dec 31, 2024 | 55.60 Mn |
| Sep 30, 2024 | 54.10 Mn |
| Sep 30, 2024 | 54.10 Mn |
| Jun 30, 2024 | 39.20 Mn |
| Jun 30, 2024 | 39.20 Mn |
| Mar 31, 2024 | 36.20 Mn |
| Mar 31, 2024 | 36.20 Mn |